Siemens and Invivo Partner to Offer Computer-Aided-Detection System For MRI; DynaCAD to be Integrated with MAGNETOM MRI Systems
November 03 2005 - 12:02PM
Business Wire
Siemens Medical Solutions (NYSE:SI) and Invivo Corporation, a
subsidiary of Intermagnetics General Corporation (Nasdaq:IMGC)
today announced a strategic partnership that will integrate
Invivo's computer-aided-detection (CAD) system with Siemens'
MAGNETOM magnetic resonance imaging (MRI) systems for advanced
breast MRI technology. DynaCAD(TM) will provide radiologists with
more detailed information for breast MRI exams to assist doctors in
detecting disease earlier and streamline workflow by managing the
large volume of images involved in today's studies. "Breast cancer
is the most common malignancy among women in the United States and
is second only to lung cancer in all cancer-related deaths," said
Nancy Gillen, vice president, MRI Division, Siemens Medical
Solutions. "It is essential to identify and administer treatment at
an early stage. The combination of Siemens' MRI technologies and
Invivo's CAD system will supply doctors with a powerful tool that
enables them to diagnose breast disease in patients earlier." With
an estimated 211,240 new breast cancer cases expected to occur and
a prediction of 40,410 related deaths in the U.S. in 2005(1), the
need for earlier detection is evident. DynaCAD is an advanced CAD
system for analyzing magnetic resonance images, providing
physicians with a number of new tools for improving their
diagnostic confidence, workflow and throughput. The system consists
of five functional modules: -- DynaMATCH(TM) - Selectable 2D/3D
image registration for suppression of image motion artifacts and
automatic image subtraction -- DynaMAP(TM) - Functional color
parameter maps to visualize changes in MRI signal intensity --
DynaMIP(TM) - Dynamic maximum intensity projections for interactive
functional 3D visualization -- DynaFLOW(TM) - Interactive access to
time-intensity curve data -- DynaLOC(TM) - Automatic calculation of
target coordinates for MRI-guided interventions for improved speed
and accuracy "We look forward to expanding our collaborative
efforts with Siemens by providing their MAGNETOM customers with the
best possible solutions for MRI mammography," said Thomas Tynes,
director, Interventional MRI Business Group, Invivo Corporation.
"The addition of DynaCAD to the existing line of Siemens-certified
Invivo breast MRI coils and biopsy systems provides a
comprehensive, fully-integrated approach to breast MRI diagnostics
and intervention." The integrated solution of DynaCAD and Siemens'
MRI systems will be distributed by Siemens on a worldwide basis for
MAGNETOM MRI users and includes the MAGNETOM Trio(TM), MAGNETOM
Espree(TM), MAGNETOM Avanto(TM) and MAGNETOM Symphony(TM). Invivo
currently provides a wide variety of Siemens-certified products for
the MRI mammography market, and the introduction of DynaCAD further
expands this partnership by providing a complete solution approach
to MRI breast care. Siemens Medical Solutions of Siemens AG
(NYSE:SI) with headquarters in Malvern, Pennsylvania and Erlangen,
Germany, is one of the largest suppliers to the healthcare industry
in the world. The company is known for bringing together innovative
medical technologies, healthcare information systems, management
consulting, and support services, to help customers achieve
tangible, sustainable, clinical and financial outcomes. Employing
approximately 31,000 people worldwide and operating in more than
120 countries, Siemens Medical Solutions reported sales of 7.07
billion EUR, orders of 8.12 billion EUR and group profit of 1.05
billion EUR for fiscal 2004. More information can be obtained by
visiting http://www.usa.siemens.com/medical-pressroom. Invivo
Corporation is a wholly-owned subsidiary of Intermagnetics General
Corporation (NASDAQ:IMGC). Intermagnetics (www.intermagnetics.com)
draws on the financial strength, operational excellence and
technical leadership in the market of Magnetic Resonance Imaging
(MRI) as well as its expanding businesses within Medical Devices
that encompass Invivo Diagnostic Imaging (focusing on MRI
components & imaging sub-systems) and Invivo Patient Care
(focusing on monitoring & other patient care devices).
Intermagnetics is also a prominent participant in superconducting
applications for Energy Technology. The company has a more than
30-year history as a successful developer, manufacturer and
marketer of superconducting materials, high-field magnets, medical
systems & components and other specialized high-value added
devices. (1)Cancer Facts and Figures 2005, American Cancer Society
PHOTOGRAPHY AVAILABLE UPON REQUEST
Intermagnetics General (NASDAQ:IMGC)
Historical Stock Chart
From Feb 2025 to Mar 2025
Intermagnetics General (NASDAQ:IMGC)
Historical Stock Chart
From Mar 2024 to Mar 2025